Alcohol, tobacco, and prescription drugs: The relationship with illicit drugs in the treatment of substance users

Substance Use and Misuse

Volumn 47, Issue 8-9, 2012, Pages 963-971

  Teesson, Maree ^a   Farrugia, Philippa ^a   Mills, Katherine ^a   Hall, Wayne ^b   Baillie, Andrew ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

Author keywords

alcohol use disorder; comorbidity; substance use disorder; treatment outcome

Indexed keywords

PRESCRIPTION DRUG; STREET DRUG;

ADDICTION; ALCOHOLISM; ARTICLE; COMORBIDITY; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; RESEARCH; SMOKING; TREATMENT OUTCOME; TWINS;

ALCOHOLISM; COMORBIDITY; FEMALE; HUMANS; MALE; PRESCRIPTION DRUGS; PROSPECTIVE STUDIES; RESEARCH; SMOKING; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; TWIN STUDIES AS TOPIC;

EID: 84862529275     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2012.663283     Document Type: Review

References (102)

1. Agrawal, A., & Lynskey, M. T. (2009). Tobacco and cannabis cooccurence: Does route of administration matter?, Drug and Alcohol Dependence, 99, 240-247.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, 4th Ed., text revision.Washington DC, American Psychiatric Association.
3. Andrews, G., Hall,W. D., Teesson, M.,&Henderson, S. (1999). The mental health of Australians. Canberra: Mental Health Branch: Commonwealth Department of Health and Aged Care.
4. Andrews, G., Henderson, S., & Hall, W. D. (2001). Prevalence, comorbidity, disability and service utilisation: Overview of the Australian National Mental Health Survey. British Journal of Psychiatry, 178, 145-153. (Pubitemid 32158076)
5. Andrews, G., & Peters, L. (1998). Psychometric properties of the CIDI. Social Psychiatry and Psychiatric Epidemiology, 33(2), 80-88.
6. Angold, A., Costello, E. J., & Erkanli, A. (2003). Comorbidity. Journal of Child Psychology and Psychiatry, 40(1), 57-87. (Pubitemid 29051937)
7. Anton, R. F., O'Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., et al. (2006). Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence. Journal of the American Medical Association, 295(17), 2003-2017.
8. Berkson, J. (1947). Limitations of the application of fourfold table analysis to hospital data. Biometrics Bulletin, 2, 47-53.
9. Bleich, A., Gelkopf, M., Weizman, T., & Adelson, M. (2002). Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: Characteristics and a pharmacotherapeutic approach. Israel Journal of Psychiatry and Related Sciences, 39(2), 104-112. (Pubitemid 44394776)
10. Burling, T. A., Burling, A. S., & Latini, D. (2001). A controlled smoking cessation trial for substance-dependent patients. Journal of Consulting and Clinical Psychology, 69(2), 295-304. (Pubitemid 32488288)
11. Burns, L., & Teesson, M. (2002). Alcohol use disorders comorbid with anxiety, depression and drug use disorders: Findings from the Australian National Survey of Mental Health and Well Being. Drug and Alcohol Dependence, 68(3), 299-307. (Pubitemid 35232565)
12. Burns, L., Teesson, M., & O'Neill, K. (2005). The impact of comorbid anxiety and depression on alcohol treatment outcomes. Addiction, 100(6), 787-796. (Pubitemid 40769823)
13. Campbell, B. K., Wander, N., Stark, M. J., & Holbert, T. (1995). Treating cigarette smoking in drug-abusing clients. Journal of Substance Abuse Treatment, 12(2), 89-94.
14. Carroll, K. M., Fenton, L. R., Ball, S. A., Nich, C., Frankforter, T. L., Shi, J., et al. (2004). Efficacy of Disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: A randomized placebo-controlled trial. Archives of General Psychiatry, 61(3), 264-272. (Pubitemid 38295828)
15. Cerda, M., Sagdeo, A., & Galea, S. (2008). Comorbid forms of psychopathology: Key patterns and future research directions. Epidemiologic Reviews, 30(1), 155-177.
16. Coffey, C., Lynskey, M., Wolfe, R., & Patton, G. C. (2000). Initiation and progression of cannabis use in a population-based Australian adolescent longitudinal study. Addiction, 95(11), 1679-1690.
17. Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the National Epidemiologic Survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566-576. (Pubitemid 46718289)
18. Copeland, J., Swift,W.,&Rees,V. (2001). Clinical profile of participants in a brief intervention program for cannabis use disorder. Journal of Substance Abuse Treatment, 20(1), 45-52. (Pubitemid 32178180)
19. Darke, S., Ross, J., Mills, K., Teesson, M., Williamson, A., & Havard, A. (2009). Benzodiazepine use among heroin users: Baseline use, current use and clinical outcome. Drug and Alcohol Review, 28(3), 243-249.
20. De Sousa, A., & De Sousa, A. (2005). An open randomized study comparing Disulfiram and Acamprosate in the treatment of alcohol dependence. Alcohol and Alcoholism, 40(6), 545-548. (Pubitemid 41600008)
21. Degenhardt, L., & Hall, W. (2001). The relationship between tobacco use, substance-use disorders and mental health: Results from the National Survey of Mental Health and Well-being. Nicotine and Tobacco Research, 3, 225-234. (Pubitemid 32821650)
22. Degenhardt, L., & Hall, W. (2003). Patterns of co-morbidity between alcohol use and other substance use in the Australian population. Drug and Alcohol Review, 22(1), 7-13. (Pubitemid 36419836)
23. Degenhardt, L., Hall, W. D., & Lynskey, M. T. (2001). Alcohol, cannabis and tobacco use among Australians: A comparison of their associations with other drug use, other drug use disorders, affective and anxiety disorders, and psychosis. Addiction, 96, 1603-1614.
24. Farrell, M., Howes, S., Bebbington, P., Brugha, T., Jenkins, R., Lewis, G., et al. (2001). Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. British Journal of Psychiatry, 179, 432-437. (Pubitemid 33097166)
25. Fergusson, D. M., & Horwood, L. J. (1997). Early onset cannabis use and psychosocial adjustment in young adults. Addiction, 92(3), 279-296. (Pubitemid 27141944)
26. Flannery, B. A., Morgenstern, J., McKay, J. R.,Wechsberg,W. M., & Litten, R. Z. (2004). Co-occurring alcohol and cocaine dependence: Recent findings from clinical and field studies. Alcoholism: Clinical and Experimental Research, 28(6), 976-981. (Pubitemid 38780575)
27. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). 'Mini-Mental State': A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
28. Garbutt, J. C., Kranzler, H. R., O'Malley, S. S., Gastfriend, D. R., Pettinati, H. M., & Silverman, B. L., et al. (2005). Efficacy and tolerability of long-acting injectable Naltrexone for alcohol dependence: A randomized controlled trial. Journal of the American Medical Association, 293(13), 1617-1625. (Pubitemid 40471792)
29. George, T. P., Chawarski, M. C., Pakes, J., Carroll, K. M., Kosten, T. R., & Schottenfeld, R. S. (2000). Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: A preliminary trial. Biological Psychiatry, 47(12), 1080-1086. (Pubitemid 30336217)
30. Gossop, M., Marsden, J., Stewart, D., & Rolfe, A. (2000). Patterns of drinking and drinking outcomes among drug misusers: 1-year follow-up results. Journal of Substance Abuse Treatment, 19(1), 45-50. (Pubitemid 30386995)
31. Grant, B. F., Dawson, D. A., & Hasin, D. S. (2001). The alcohol use disorder and associated disabilities interview schedule - DSMIV version. Bethesda, Md: National Institute on Alcohol Abuse and Alcoholism.
32. Grant, B. F., Goldstein, R. B., Chou, S. P., Huang, B., Stinson, F. S., Dawson, D. A., et al. (2009). Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: Results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Molecular Psychiatry, 14, 1051-1066.
33. Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., et al. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61, 807-816. (Pubitemid 39031120)
34. Grant, J. D., Scherrer, J. F., Lynskey, M. T., Lyons, M. J., Eisen, S. A., Tsuang, M. T., et al. (2006). Adolescent alcohol use is a risk factor for adult alcohol and drug dependence: Evidence from a twin design. Psychological Medicine, 36, 109-118. (Pubitemid 41825351)
35. Grassi,M. C., Cioce, A. M., Guidici, F. D., Antonilli, L.,&Nencini, P. (2007). Short-term efficacy of Disulfiram or Naltrexone in reducing positive urinalysis for both cocaine and cocaethylene in cocaine abusers: A pilot study. Pharmacological Research, 55(2), 117-121. (Pubitemid 46201774)
36. Hall,W., Degenhardt, L., & Teesson, M. (2004). Cannabis and psychotic disorders: An update. Drug and Alcohol Review, 23(4), 433-443.
37. Hall, W., Degenhardt, L., & Teesson, M. (2009). Understanding comorbidity between substance use, anxiety and affective disorders: Broadening the research base. Addictive Behaviors, 34(6-7), 526-530.
38. Hasin,D. S., Stinson, F. S.,Ogburn, E.,&Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64(7), 830-842. (Pubitemid 47026379)
39. Hersh, D., Van Kirk, J. R., & Kranzler, H. R. (1998). Naltrexone treatment of co-morbid alcohol and cocaine use disorders. Psychopharmacology, 139(1-2), 44-52. (Pubitemid 28416881)
40. Higgins, S. T., Budney, A. J., Bickel, W. K., & Foerg, F. E. (1994). Incentives improve outcome in outpatient behavioral treatment of cocaine dep
41. Hill, A. B. (1965). The environment and disease: Associations or causation? Proceedings of the Royal Society of Medicine 58, 95-300.
42. Hill A.B.Principles of Medical Statistics, 8th ed. London: The Lancet.1966
43. Hill, A. B. (1966). Principles of medical statistics, 8th ed. London: The Lancet. Jenkins, R., Bebbington, P., Brugha, T., Farrell, M., Gill, B., Lewis, G., et al. (1997). The national psychiatric morbidity surveys of Great Britain: Strategy and methods. Psychological Medicine, 27(4), 765-774.
44. Jessor, R., & Jessor, S. L. (1977). Problem behavior and psychosocial development: A longitudinal study of youth.NewYork: Academic Press.
45. John, U., Meyer, C., Rumpf, H. J., & Hapke, U. (2004). Smoking, nicotine dependence and psychiatric comorbidity:Apopulationbased study including smoking cessation after three years. Drug and Alcohol Dependence, 76(3), 287-295. (Pubitemid 39556358)
46. Kandel, D. (1975). Stages in adolescent involvement in drug use. Science, 190(4217), 912-914.
47. Kendler, K. S., & Prescott, C. A. (2006). Genes, environment, and psychology: Understanding the causes of psychiatric and substance use disorders. New York: Guilford Press.
48. Kessler, R. C. (1995). The epidemiology of psychiatric comorbidity. In Tsuang, M., Tohen, M. & Zahner, G. (Eds.), Textbook of psychiatric epidemiology (pp. 179-179). New York: JohnWiley and Sons.
49. Kessler, R. C., Berglund, P., Chiu, W. T., Demler, O., Heeringa, S., Hiripi, E., et al. (2004). The US National Comorbidity Survey Replication (NCS-R): Design and field procedures. International Journal of Methods in Psychiatric Research, 13(2), 69-92. (Pubitemid 39199022)
50. Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617-627. (Pubitemid 40973437)
51. Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8-19. (Pubitemid 24028993)
52. Kessler, R. C., & Ustun, T. B. (2004). The World Mental Health (WMH) survey initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). International Journal of Methods in Psychiatric Research, 13(2), 93-121.
53. Kessler, R. C., &Wang, P. S. (2008). The descriptive epidemiology of commonly occurring mental disorders in the United States. Annual Review of Public Health, 29, 115-129. (Pubitemid 351600402)
54. Lai, S., Lai, H., Page, B., & McCoy, C. B. (2000). The association between cigarette smoking and drug abuse in the United States. Journal of Addictive Diseases, 19(4), 11-24.
55. Lewinsohn, P. M., Rohde, P., & Brown, R. A. (1999). Level of current and past adolescent cigarette smoking as predictors of future substance use disorders in young adulthood. Addiction, 94(6), 913-921.
56. Lewis, G., Pelosi, A. J., Araya, R., & Dunn, G. (1992). Measuring psychiatric disorder in the community: A standardized assessment for use by lay interviewers. Psychological Medicine, 22(2), 465-486.
57. Lynskey, M. T., Heath, A. C., Bucholz, K. K., Slutske,W. S., Madden, P. A., Nelson, E. C., et al. (2003). Escalation of drug use in early-onset cannabis users vs co-twin controls. Journal of the American Medical Association, 289(4), 427-433. (Pubitemid 36119962)
58. Lytton, H. (1990). Child and parent effects in boys' conduct disorder: A reinterpretation. Development Psychology, 26(5), 683-697.
59. Magura, S. (2000). Introduction: Program quality in substance dependency treatment. Substance Use and Misuse, 35(12-14), 1617-1627. (Pubitemid 32004721)
60. McKay, J. R., Alterman, A. I., Rutherford, M. J., Cacciola, J. S., & McLellan, A. T. (1999). The relationship of alcohol use to cocaine relapse in cocaine dependent patients in an aftercare study. Journal of Studies on Alcohol, 60(2), 176-180. (Pubitemid 29091599)
61. Mengis, M. M., Maude-Griffin, P. M., Delucchi, K., & Hall, S. M. (2002). Alcohol use affects the outcome of treatment for cocaine abuse. American Journal on Addictions, 11(3), 219-227. (Pubitemid 34856438)
62. Miller, N. (1991). Special problems of the alcohol and multipledrug dependent: Clinical interactions and detoxification. In R. Frances & S. Miller (Eds.), Clinical textbook of addictive disorders (pp. 194-218). New York: Guildford Press.
63. Moore, B. A., & Budney, A. J. (2001). Tobacco smoking in marijuana-dependent outpatients. Journal of Substance Abuse, 13(4), 583-596. (Pubitemid 38198164)
64. Navaratnam, V., & Foong, K. (1990). Opiate dependence - The role of benzodiazepines. Current Medical Research and Opinion, 11(10), 620-630. (Pubitemid 20069449)
65. Oslin, D. W., Pettinati, H. M., Volpicelli, J. R., Wolf, A. L., Kampman, K. M., & O'Brien, C. P. (1999). The effects of Naltrexone on alcohol and cocaine use in dually addicted patients. Journal of Substance Abuse Treatment, 16(2), 163-167. (Pubitemid 29066428)
66. Patton, G. C., Coffey, C., Carlin, J. B., Sawyer, S. M., & Lynskey, M. (2005). Reverse gateway?. Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction, 100(10), 1518-1525. (Pubitemid 41442321)
67. Petrakis, I. L., Carroll, K. M., Nich, C., Gordon, L. T., McCance-Katz, E. F., Frankforter, T., et al. (2000).Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction, 95(2), 219-228. (Pubitemid 30111242)
68. Pettinati, H. M., Kampman, K. M., Lynch, K. G., Suh, J. J., Dackis, C. A., Oslin, D. W., et al. (2008). Gender differences with highdose naltrexone in patients with co-occuring cocaine and alcohol dependence. Journal of Substance Abuse Treatment, 34, 378-390. (Pubitemid 351609292)
69. Portney, L. G., & Watkins, M. P. (2000). Foundations of clinical research, 2nd ed. New Jersey, NJ: Prentice Hall.
70. Prochaska, J. J. (2010). Failure to treat tobacco use in mental health and addiction treatment settings: A form of harm reduction? Drug and Alcohol Dependence, 110(3), 177-182.
71. Project MATCH Research Group. (1997). Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol, 58, 7-29.
72. Project MATCH Research Group. (1998). Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research, 22(6), 1300-1311.
73. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., et al. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Journal of the American Medical Association, 264(19), 2511-2518.
74. Reinherz, H. Z., Giaconia, R. M., Hauf, A. M., Wasserman, M. S., & Paradis, A. D. (2000). General and specific childhood risk factors for depression and drug disorders by early adulthood. Journal of the American Academy of Child and Adolescent Psychiatry, 39(2), 223-231. (Pubitemid 30081966)
75. Roll, J. M., Higgins, S. T., Budney, A. J., Bickel, W. K., & Badger, G. J. (1996). A comparison of cocaine-dependent cigarette smokers and non-smokers on demographic, drug use and other characteristics. Drug and Alcohol Dependence, 40(3), 195-201. (Pubitemid 26131382)
76. Ross, J., & Darke, S. (2000). The nature of benzodiazepine dependence among heroin users in Sydney, Australia. Addiction, 95(12), 1785-1793. (Pubitemid 32055816)
77. Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A., et al. (2005). The characteristics of heroin users entering treatment: Findings from the Australian Treatment Outcomes Study (ATOS). Drug and Alcohol Review, 24(5), 411-418. (Pubitemid 43024040)
78. Rutter, M. (1994). Family discord and conduct disorder: Cause, consequence, or correlate?. Journal of Family Psychology, 8(2), 170-186.
79. Schiff, M., Levit, S., & Moreno, S. C. (2007). Retention and illicit drug use among methadone patients in Israel: A gender comparison. Addictive Behaviors, 32(10), 2108-2119. (Pubitemid 47198946)
80. Schmitz, J. M., Bordnick, P. S., Kearney, M. L., Fuller, S. M., & Breckenridge, J. K. (1997). Treatment outcome of cocainealcohol dependent patients. Drug and Alcohol Dependence, 47, 55-61. (Pubitemid 27374636)
81. Schmitz, J. M., Stotts, A. L., Sayre, S. L., DeLaune, K. A., & Grabowski, J. (2004). Treatment of cocaine-alcohol dependence with Naltrexone and relapse prevention therapy. American Journal on Addictions, 13(4), 333-341. (Pubitemid 39244792)
82. Shoptaw, S., Rotheram-Fuller, E., Yang, X., Frosch, D., Nahom, D., Jarvik, M. E., et al. (2002). Smoking cessation in methadone maintenance. Addiction, 97(10), 1317-1328.
83. Simpson, D. D., Joe, G. W., Broome, K. M., Hiller, M. L., Knight, K., & Rowan-Szal, G. A. (1997). Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11(4), 279-293. (Pubitemid 28046590)
84. Slade, T., Johnston, A., Oakley Browne, M. A., Andrews, G., & Whiteford, H. (2009). 2007 National Survey of Mental Health and Wellbeing: Methods and key findings. Australian and New Zealand Journal of Psychiatry, 43(7), 594-605.
85. Stein, M. D., Weinstock, M. C., Herman, D. S., Anderson, B. J., Anthony, J. C., & Niaura, R. (2006). A smoking cessation intervention for the methadone-maintained. Addiction, 101(4), 599-607. (Pubitemid 43375623)
86. Stenbacka, M., Beck, O., Leifman, A., Romelsj, A., & Helander, A. (2007). Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment. Drug and Alcohol Review, 26(1), 55-63.
87. Story, J., & Stark, M. J. (1991). Treating cigarette smoking in methadone maintenance clients. Journal of Psychoactive Drugs, 23(2), 203-215.
88. Teesson, M., Hall, W., Slade, T., Mills, K., Grove, R., Mewton, L., et al. (2010). Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: Findings of the 2007 National Survey of Mental Health and Welbeing. Addiction, 105, 1-10.
89. Teesson, M., Mills, K., Ross, J., Darke, S., Williamson, A., & Havard, A. (2008). The impact of treatment on 3 years' outcome for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Addiction, 103(1), 80-88. (Pubitemid 350233406)
90. Teesson, M., Slade, T., & Mills, K. (2009). Comorbidity in Australia: Findings of the 2007 National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry, 43(7), 606-614.
91. Timberlake, D. S., Haberstick, B. C., Hopfer, C. J., Bricker, J., Sakai, J. T., Lessem, J. M., et al. (2007). Progression from marijuana use to daily smoking and nicotine dependence in a national sample ofUS adolescents. Drug and Alcohol Dependence, 88(2-3), 272-281. (Pubitemid 46486689)
92. Tonnesen, P., Paoletti, P., Gustavsson, G., Russell, M. A., Saracci, R., Gulsvik, A., et al. (1999). Higher dosage nicotine patches increase one-year smoking cessation rates: Results from the European CEASE trial. European Respiratory Journal, 13, 238-246. (Pubitemid 29086814)
93. Tsuang, M. T., Bar, J. L., Harley, R. M., & Lyons,M. J. (2001). The Harvard twin study of substance abuse: What we have learned. Harvard Review of Psychiatry, 9(6), 267-279. (Pubitemid 33010369)
94. Tullis, L. M., Dupont, R., Frost-Pineda, K., & Gold, M. S. (2003). Marijuana and tobacco: A major connection? Journal of Addictive Diseases, 22(3), 51-62.
95. Ware, J. E., Kosinski, M., & Keller, S. D. (1996). A 12-item short form health survey. Medical Care, 34, 220-233.
96. Williamson, A., Darke, S., Ross, J., & Teesson, M. (2006). The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence. Drug and Alcohol Dependence, 81(3), 293-300. (Pubitemid 43152456)
97. Wiseman, E. J., & McMillan, D. E. (1996). Combined use of cocaine with alcohol and cigarettes. American Journal of Drug and Alcohol Abuse, 22(4), 577-587. (Pubitemid 26361028)
98. Wiseman, E. J., Williams, D. K., & McMillan, D. E. (2005). Effectiveness of payment for reduced carbon monoxide levels and noncontingent payments on smoking behaviors in cocaineabusing outpatients wearing nicotine or placebo patches. Experimental and Clinical Psychopharmacology, 13(2), 102-110.
99. Wittchen, H.-U., Beloch, E., Garczynski, E., Holly, A., Lachner, G., Perkonigg, A., et al. (1995). Munchener Composite International Diagnostic Interview (M-CIDI), version 2.2. Munich: Max-Planck-Institut fur Psychiatrie.
100. World Health Organization. 1990). Composite International Diagnostic Interview CIDI), Version 1.0. Geneva: World Health Organization
101. World Health Organization. 1993). The ICD-10 classification of mental and behavioural disorders. Geneva:
102. Young, S. E., Mikulich, S. K., Goodwin, M. B., Hardy, J., Martin, C. L., Zoccolillo, M. S., et al. (1995). Treated delinquent boys' substance use: Onset, pattern, relationship to conduct and mood disorders. Drug and Alcohol Dependence, 37, 149-162.